文献速递脑血管病外科

基于就诊时用药情况评估动脉瘤破裂「风险」:正本清源

Medications and "Risk" of Aneurysm Rupture Based on Presentation: Setting the Record Straight.
PubMed 文献 · World Neurosurg · 2024-05-31

破裂组68%未用任何药物,未破裂组为22%(P<0.001);未破裂组51%使用2-5种药物,破裂组为15%(P<0.001);未破裂组12%使用超过5种药物,破裂组为1%(P<0.001)。35种药物与未破裂就诊相关(P<0.05),无药物与破裂就诊相关。作者认为不能基于就诊时用药分析推断药物与破裂「风险」的关系。

要点

  • 破裂组68%未用任何药物,未破裂组为22%(P<0.001)。
  • 未破裂组51%使用2-5种药物,破裂组为15%(P<0.001)。
  • 35种药物与未破裂就诊相关(P<0.05),无药物与破裂就诊相关。

核心结论

  • 不能基于就诊时用药分析推断药物与动脉瘤破裂「风险」的关系。
  • 研究识别出35种与未破裂就诊相关的药物,但作者怀疑每种药物均「保护」 against 动脉瘤破裂。

研究设计与样本

  • 比较破裂与未破裂病例的人口学、临床特征(破裂状态)及就诊时用药情况。

主要发现

  • 破裂组68%未用任何药物,未破裂组为22%(P<0.001)。
  • 未破裂组51%使用2-5种药物,破裂组为15%(P<0.001)。
  • 未破裂组12%使用超过5种药物,破裂组为1%(P<0.001)。
  • 35种不同药物与未破裂就诊相关,包括所有评估的抗血小板药、抗高血压药、抗酸药、肺部吸入剂及精神科药物(P<0.05);无药物与就诊时破裂相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Studies assessing aneurysm rupture "risk" based on comparative retrospective analyses of medications taken on presentation may be subject to presentation bias. Are patients with ruptured aneurysms simply less likely to be taking medications than those with unruptured aneurysms? METHODS: A retrospective chart review was conducted among patients with treated aneurysms from June 2016 to July 2023. A step-wise comparison of demographics, clinical characteristics (rupture status), and medications taken upon presentation was performed between ruptured and unruptured cases. RESULTS: One thousand three hundred eleven patients with intracranial aneurysms were included. The majority of patients presenting with ruptured aneurysms took no medications (68%), in contrast to 22% with unruptured aneurysms (P < 0.001). The majority of patients with unruptured aneurysms took 2-5 medications (51%), in contrast to 15% of patients with ruptured aneurysms taking 2-5 medications (P < 0.001). Twelve percent of patients with unruptured aneurysms took more than 5 medications, while only 1% with ruptured aneurysms did (P < 0.001). Thirty-five different medications were associated with unruptured presentation, including all evaluated antiplatelet agents, anti-hypertensives, antacids, pulmonary inhalers, and psychiatric medications (P < 0.05); no medications were associated with rupture on presentation. CONCLUSIONS: One cannot derive conclusions about medications and "risk" of rupture based on analyses at the time of presentation. This study identifies 35 different medications that were statistically significant and associated with an unruptured presentation; it is doubtful that each is "protective" against aneurysm rupture.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hoz SS, Hudson JS, Ma L, et al. Medications and "Risk" of Aneurysm Rupture Based on Presentation: Setting the Record Straight. World Neurosurg. 2024. PMID: 38823446. doi:10.1016/j.wneu.2024.05.158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。